Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Ca2+-dependent demethylation of phosphatase PP2Ac promotes glucose deprivation-induced cell death independently of inhibiting glycolysis.

Lee HY, Itahana Y, Schuechner S, Fukuda M, Je HS, Ogris E, Virshup DM, Itahana K.

Sci Signal. 2018 Jan 9;11(512). pii: eaam7893. doi: 10.1126/scisignal.aam7893.

PMID:
29317521
2.

Specificity of research antibodies: "trust is good, validation is better".

Ogris E, Sontag E, Wadzinski B, Narla G.

Hum Pathol. 2018 Feb;72:199-201. doi: 10.1016/j.humpath.2017.12.003. Epub 2017 Dec 13. No abstract available.

PMID:
29247663
3.
4.

Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation.

Yabe R, Miura A, Usui T, Mudrak I, Ogris E, Ohama T, Sato K.

PLoS One. 2015 Dec 17;10(12):e0145226. doi: 10.1371/journal.pone.0145226. eCollection 2015.

5.

Axonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulum.

Montgomery TR, Steinkellner T, Sucic S, Koban F, Schüchner S, Ogris E, Sitte HH, Freissmuth M.

J Neurosci. 2014 Apr 30;34(18):6344-6351. doi: 10.1523/JNEUROSCI.2991-13.2014.

6.

Budding yeast greatwall and endosulfines control activity and spatial regulation of PP2A(Cdc55) for timely mitotic progression.

Juanes MA, Khoueiry R, Kupka T, Castro A, Mudrak I, Ogris E, Lorca T, Piatti S.

PLoS Genet. 2013;9(7):e1003575. doi: 10.1371/journal.pgen.1003575. Epub 2013 Jul 4.

7.

Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation.

Romanov J, Walczak M, Ibiricu I, Schüchner S, Ogris E, Kraft C, Martens S.

EMBO J. 2012 Nov 14;31(22):4304-17. doi: 10.1038/emboj.2012.278. Epub 2012 Oct 12.

8.

M-Track: detecting short-lived protein-protein interactions in vivo.

Zuzuarregui A, Kupka T, Bhatt B, Dohnal I, Mudrak I, Friedmann C, Schüchner S, Frohner IE, Ammerer G, Ogris E.

Nat Methods. 2012 Jun;9(6):594-6. doi: 10.1038/nmeth.2017. Epub 2012 May 13.

9.

Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells.

Sontag JM, Nunbhakdi-Craig V, Mitterhuber M, Ogris E, Sontag E.

J Neurochem. 2010 Dec;115(6):1455-65. doi: 10.1111/j.1471-4159.2010.07049.x. Epub 2010 Nov 4.

10.

A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Simboeck E, Sawicka A, Zupkovitz G, Senese S, Winter S, Dequiedt F, Ogris E, Di Croce L, Chiocca S, Seiser C.

J Biol Chem. 2010 Dec 24;285(52):41062-73. doi: 10.1074/jbc.M110.184481. Epub 2010 Oct 14.

11.

Lamin A precursor induces barrier-to-autointegration factor nuclear localization.

Capanni C, Cenni V, Haraguchi T, Squarzoni S, Schüchner S, Ogris E, Novelli G, Maraldi N, Lattanzi G.

Cell Cycle. 2010 Jul 1;9(13):2600-10. doi: 10.4161/cc.9.13.12080.

PMID:
20581439
12.

Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.

Roblek M, Schüchner S, Huber V, Ollram K, Vlcek-Vesely S, Foisner R, Wehnert M, Ogris E.

PLoS One. 2010 May 13;5(5):e10604. doi: 10.1371/journal.pone.0010604.

13.

Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Schiessel R, Ogris E, Hinterberger W, Hamilton G.

J Gastrointest Surg. 2009 Nov;13(11):2020-6. doi: 10.1007/s11605-009-0992-6. Epub 2009 Sep 2.

PMID:
19727975
14.

Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer.

Buxhofer-Ausch V, Ausch C, Kitzweger E, Mollik M, Reiner-Concin A, Ogris E, Stampfl M, Hamilton G, Schiessel R, Hinterberger W.

Colorectal Dis. 2010 Aug;12(8):776-82. doi: 10.1111/j.1463-1318.2009.01950.x. Epub 2009 May 18.

PMID:
19456841
15.

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Hinterberger W, Ogris E, Schiessel R, Hamilton G.

Eur J Surg Oncol. 2009 Nov;35(11):1164-8. doi: 10.1016/j.ejso.2009.02.007. Epub 2009 Feb 28.

PMID:
19254831
16.

Generation of active protein phosphatase 2A is coupled to holoenzyme assembly.

Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, Lackner DH, Ogris E.

PLoS Biol. 2007 Jun;5(6):e155.

17.

Expression of protein phosphatase 2A mutants and silencing of the regulatory B alpha subunit induce a selective loss of acetylated and detyrosinated microtubules.

Nunbhakdi-Craig V, Schuechner S, Sontag JM, Montgomery L, Pallas DC, Juno C, Mudrak I, Ogris E, Sontag E.

J Neurochem. 2007 May;101(4):959-71. Epub 2007 Mar 23.

18.

Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.

Ausch C, Dandachi N, Buxhofer-Ausch V, Balic M, Huber K, Bauernhofer T, Ogris E, Hinterberger W, Braun S, Schiessel R.

Clin Chem Lab Med. 2007;45(3):351-6.

PMID:
17378731
19.

Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation.

Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T.

J Neurosci. 2007 Mar 14;27(11):2751-9.

20.

Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice.

Schild A, Isenmann S, Tanimoto N, Tonagel F, Seeliger MW, Ittner LM, Kretz A, Ogris E, Götz J.

Mech Dev. 2006 May;123(5):362-71. Epub 2006 Mar 24.

21.

Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I.

Riedel CG, Katis VL, Katou Y, Mori S, Itoh T, Helmhart W, Gálová M, Petronczki M, Gregan J, Cetin B, Mudrak I, Ogris E, Mechtler K, Pelletier L, Buchholz F, Shirahige K, Nasmyth K.

Nature. 2006 May 4;441(7089):53-61. Epub 2006 Mar 15.

PMID:
16541024
22.

The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor.

Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M, Nanoff C.

Mol Pharmacol. 2006 Apr;69(4):1083-94. Epub 2005 Dec 9.

24.

Advancements in the diagnosis of acute appendicitis in children and adolescents.

Blab E, Kohlhuber U, Tillawi S, Schweitzer M, Stangl G, Ogris E, Rokitansky A.

Eur J Pediatr Surg. 2004 Dec;14(6):404-9.

PMID:
15630642
25.

Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis.

Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL 3rd.

J Neuropathol Exp Neurol. 2004 Oct;63(10):1080-91.

PMID:
15535135
26.

A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.

Buxhofer-Ausch V, Ruckser R, Kier P, Habertheuer KH, Zelenka P, Tatzreiter G, Ausch C, Schmid I, Hruby W, Reiner-Concin A, Sebesta C, Ogris E, Hinterberger-Fischer M, Hinterberger W.

Eur J Haematol. 2004 Aug;73(2):143-6.

PMID:
15245515
27.

Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases.

Kurtev V, Margueron R, Kroboth K, Ogris E, Cavailles V, Seiser C.

J Biol Chem. 2004 Jun 4;279(23):24834-43. Epub 2004 Mar 31.

28.

Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology.

Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL 3rd.

J Neuropathol Exp Neurol. 2004 Apr;63(4):287-301.

PMID:
15099019
29.

Altering the holoenzyme composition and substrate specificity of protein phosphatase 2A.

Fellner T, Piribauer P, Ogris E.

Methods Enzymol. 2003;366:187-203. No abstract available.

PMID:
14674250
30.

Identification of a subunit of a novel Kleisin-beta/SMC complex as a potential substrate of protein phosphatase 2A.

Yeong FM, Hombauer H, Wendt KS, Hirota T, Mudrak I, Mechtler K, Loregger T, Marchler-Bauer A, Tanaka K, Peters JM, Ogris E.

Curr Biol. 2003 Dec 2;13(23):2058-64.

31.

Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip.

Berger CE, Kröner AH, Minai-Pour MB, Ogris E, Engel A.

Bone. 2003 Sep;33(3):346-51.

PMID:
13678776
32.

A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo.

Fellner T, Lackner DH, Hombauer H, Piribauer P, Mudrak I, Zaragoza K, Juno C, Ogris E.

Genes Dev. 2003 Sep 1;17(17):2138-50.

33.

Decreased cutaneous vitamin D-synthesis in heavily melanized individuals: a rare cause for pathologic fractures of the hip.

Berger CE, Marteau R, Pabinger C, Kröner A, Ogris E, Engel A.

Wien Klin Wochenschr. 2003 Mar 31;115(5-6):186-90.

PMID:
12741080
34.

[Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer].

Buxhofer V, Ausch C, Ogris E, Schiessel R, Hinterberger W.

Acta Med Austriaca Suppl. 2002;59:54-7. Review. German.

PMID:
12506761
35.

[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].

Hinterberger W, Buxhofer V, Ogris E, Zelenka P, Kier P, Ruckser R, Dorner S, Habertheuer KH, Vedovelli H, Schindler S, Hinterberger-Fischer M.

Acta Med Austriaca Suppl. 2002;59:2-8. Review. German.

PMID:
12506753
36.

Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex.

Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL 3rd, Sontag E.

J Cell Biol. 2002 Sep 2;158(5):967-78. Epub 2002 Aug 26.

37.

Comparison of biochemical markers of bone metabolism in serum and femur aspirates.

Berger CE, Kröner A, Thomas E, Kristen KH, Ogris E, Engel A.

Clin Orthop Relat Res. 2002 Feb;(395):174-9.

PMID:
11937878
38.
39.

Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters.

Metzenbauer M, Hafner E, Hoefinger D, Schuchter K, Stangl G, Ogris E, Philipp K.

Placenta. 2001 Jul;22(6):602-5.

PMID:
11440550
40.
41.
42.

Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?

Hinterberger-Fischer M, Ogris E, Kier P, Bauer K, Kittl E, Habertheuer KH, Ruckser R, Schmid A, Selleny S, Fangl M, Sebesta C, Hinterberger W.

Am J Clin Oncol. 2000 Aug;23(4):325-9.

PMID:
10955855
43.
44.
45.

TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.

Peters-Engl C, Buxbaum P, Ogris E, Sevelda P, Medl M.

Anticancer Res. 1998 Nov-Dec;18(6B):4635-9.

PMID:
9891532
46.

Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.

Globits S, Frank H, Pacher B, Huelsmann M, Ogris E, Pacher R.

Am Heart J. 1998 Apr;135(4):592-7.

PMID:
9539472
48.

Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.

Pacher R, Stanek B, Hülsmann M, Bojic A, Berger R, Frey B, Siegel A, Kos T, Ogris E, Grimm M, Laufer G.

J Heart Lung Transplant. 1997 Aug;16(8):878-81.

PMID:
9286780
49.

Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.

Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R.

J Heart Lung Transplant. 1997 May;16(5):556-62.

PMID:
9171275
50.

Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure.

Stanek B, Frey B, Hülsmann M, Koller-Strametz J, Hartter E, Schuller M, Ogris E, Maurer G, Pacher R.

Transplant Proc. 1997 Feb-Mar;29(1-2):595-6. No abstract available.

PMID:
9123146

Supplemental Content

Support Center